The ISS menu is about to get a lot more interesting
It sounds awful, because it almost certainly was. Over the decades, however, astronaut food has steadily improved, and while some dishes continue to require rehydration in foil packets, others actually bear some resemblance to what you might eat back on terra firma — although this sushi 'meal' doesn't really cut it.
Recommended Videos
French astronaut Sophie Adenot is one of the lucky ones. When she heads to the International Space Station (ISS) next year, she's going to be taking with her some top-class nosh created by award-winning Michelin-starred chef Anne-Sophie Pic.
Taking a welcome break from freeze-dried scrambled eggs and powdered soups, Adenot and her ISS crewmates will get to enjoy tasty dishes such as parsnip velouté with curry and smoked haddock, onion soup with pink peppercorns and gratinéed croutons, and lobster bisque with crab and caraway — and they're just the starters.
While most meals aboard the ISS are basic fare from cans or vacuum packs, every so often a special 'bonus meal' is prepared for all of the astronauts to enjoy together, partly to help with crew bonding, and partly to give everyone a welcome break from the blander menu items.
'During a mission, sharing our respective food is a way to invite our crewmates to discover more about our culture,' Adenot said. 'It's a very special bonding moment for all of us and a welcome change in our day-to-day routine. I have no doubt they'll be as enthusiastic as I am when they get a chance to taste Anne-Sophie's dishes.'
When creating the one-off menu, Pic had to consider strict rules for food aboard the ISS. For example, dishes have to be solid or contained so that crumbs or small bits don't float away in the microgravity conditions and clog up the space station's ventilation systems.
'Cooking for space means pushing the boundaries of gastronomy,' Pic said. 'With my team in my research and development lab, we embraced a thrilling challenge: preserving the emotion of taste despite extreme technical constraints.'
As NASA looks toward the first crewed missions to Mars and beyond, astronauts have also been experimenting with growing produce in microgravity, providing them with fresh food as part of a sustainable life-support system, while also boosting crew morale.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Learn About: NASA's Lucy Spacecraft Flyby With Asteroid Donaldjohanson
Learn more about the Lucy mission "fly past 52246 Donaldjohanson -NASA's Goddard Space Flight Center. Credit: NASA's Goddard Space Flight Center Dan Gallagher: Producer/Narrator Adriana Manrique Gutierrez: Animator Kel Elkins: Animator Johathan North: Animator Michael Lentz: Animator/Art Director Walt Feimer: Animation Lead Nancy Jones: Public Affairs Katherine Kretke: Public Affairs Universal Production Music: 'Nico's Journey' by Nicholas Smith [PRS]; 'Knowing Half the Future' and 'Temporal Timings' by Lee John Gretton [PRS]; 'Poly Propulsion' by Alfie Solo [PRS]
Medscape
28 minutes ago
- Medscape
Insulin Resistance Linked to Faster Cognitive Decline in AD
Insulin resistance, detected using a simple and readily available blood test, may flag cognitive decline in patients with early Alzheimer's disease (AD), preliminary results of a new study suggested. Using the triglyceride-glucose (TyG) index to measure insulin resistance, investigators found that cognitive decline was four times faster in individuals with mild cognitive impairment (MCI) due to AD who had the highest insulin resistance levels compared to those with lower levels. The findings underline the importance of risk stratification strategies and early interventions to change the trajectory of cognitive decline, lead author Bianca Gumina, MD, neurology resident, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy, told Medscape Medical News. 'The results suggest that in MCI-AD, the brain seems to be more vulnerable to metabolic stress. By identifying and addressing modifiable risk factors like metabolic health, we can use the tools we already have to potentially slow the disease course,' Gumina said. The results were presented on June 23 at the Congress of the European Academy of Neurology (EAN) 2025 in Helsinki, Finland. A 'Practical Tool' While insulin resistance has been linked to AD onset and pathology, its role in how rapidly the condition progresses has remained unclear. The single-center retrospective study included 315 patients without diabetes who had a neurodegenerative disorder (NDD) detected through cerebrospinal fluid (CSF). Of these, 210 had AD (mean age, 71.51 years; 79% men), and 115 had another NDD, mostly Lewy body dementia or frontotemporal dementia (mean age, 69.19; 60% men). Baseline measurements included neurologic evaluations, the Mini-Mental State Examination (MMSE) to test cognition, CSF biomarkers (Abeta42 or pTau181), APOE4 genotyping, and blood-brain barrier (BBB) integrity (CSF/serum albumin ratio). Follow-up assessments involved cognitive testing, typically every 6 months, with most patients followed for 3 years. Cognitive decline was defined as a loss of more than 2.5 points per year on the MMSE. Investigators measured insulin resistance with the TyG index, a metabolic marker calculated from fasting triglycerides and fasting glucose levels. The index, which Gumina called a 'practical tool,' can be obtained from standard blood tests. Researchers stratified patients into tertiles (low, medium, or high) according to TyG index levels. Exacerbating Neuroinflammation After adjusting for age, sex, baseline MMSE, disease duration, AD therapy, and BMI, the study found high TyG was significantly associated with faster cognitive decline over 3 years in a subgroup of 161 subjects with MCI (77% men) compared to those with lower TyG levels (hazard ratio, 4.08; 95% CI, 1.06-15.73). Insulin resistance may accelerate AD progression by impairing brain glucose uptake, said Gumina. This could exacerbate neuroinflammation and disrupt the BBB, 'all of which accelerate neurodegeneration,' she added. The study did link high TyG to elevated BBB permeability, but only in patients with AD. 'This supports the hypothesis that metabolic dysfunction may worsen neurodegeneration via mechanisms specifically related to AD,' said Gumina. Researchers observed an association between TyG and conversion from MCI to dementia, although this trend was not significant. Insulin resistance did not affect clinical progression in those with a neurodegenerative disease other than AD, which again likely reflects a disease-specific mechanism, said Gumina. 'AD may be the most sensitive to metabolic stress due to its underlying pathology,' she said. The study found no significant interaction between TyG and APOE4 genotype on the rate of cognitive decline. Speeding Disease Progression These new results show that insulin resistance 'influences the speed of disease progression, especially in early stages, which could be the most vulnerable in modifying the trajectory,' said Gumina. The findings could lead to more prompt identification of high-risk patients. 'By using the TyG index, we can stratify MCI patients by risk of fast progression, enabling personalized follow-up and interventions when the brain is still more responsive,' said Gumina. She recommends more widespread use of the TyG test, especially in patients with MCI or early AD. 'It's already available through routine and simple blood tests, found in every lab, so it could be used to flag patients for closer monitoring or early intervention.' Such interventions could include targeted enrollment in anti-amyloid or anti-tau clinical trials and timely introduction of lifestyle modifications and perhaps medications to improve insulin sensitivity. 'Lifestyle changes like regular exercise, a healthy diet, weight control, and managing blood pressure and cholesterol are all effective,' said Gumina. 'Some medications that modify insulin resistance are also under investigation.' The research team is investigating whether the TyG index correlates with neuroimaging biomarkers and integrating it with genetic and imaging data to improve prediction models. Important Puzzle Piece Commenting on the findings for Medscape Medical News , Sebastiaan Engelborghs, MD, PhD, professor and chair of Neurology, Vrije University Brussels, Brussels, Belgium, said the study 'adds an important piece to the Alzheimer's puzzle . ' The results highlighted how a routine metabolic marker such as the TyG index could help identify patients most likely to benefit from early, targeted interventions, said Engelborghs, who co-chaired the EAN panel on dementia and was not part of the research. And with precision neurology becoming ever more relevant, 'such noninvasive and low-cost tools could become critical in tailoring care and optimizing clinical trial design,' he added. Engelborghs agreed lifestyle interventions could affect insulin resistance and noted research shows that 45% of dementias can be prevented or delayed by modifying 14 risk factors. One such risk factor is obesity, and insulin resistance 'goes hand and hand' with obesity, he said. 'We expect that people who modify their lifestyle in order to lose weight and reduce insulin resistance will decline more slowly,' Engelborghs said.
Medscape
28 minutes ago
- Medscape
Can Periostin Serve as a Biomarker for Pediatric Urticaria?
TOPLINE: Children with chronic spontaneous urticaria (CSU) had significantly lower serum periostin levels than those without the condition. These levels did not correlate with disease activity, however. METHODOLOGY: Researchers conducted a cross-sectional study to compare serum periostin levels between children with CSU and peers without the condition. They recruited 84 children (median age, 9 years; 58.3% girls) with CSU — all receiving antihistamines — from an outpatient clinic between April 2018 and April 2019. The control children did not have any known allergic, dermatologic, or chronic systemic conditions. TAKEAWAY: Mean serum periostin levels were significantly lower in the CSU group than in controls (56.41 ng/mL vs 71.68; P = .001). Among children with CSU, those receiving a leukotriene receptor antagonist had significantly lower periostin levels than those not receiving that class of medication (44.32 vs 61.33 ng/mL; P = .009). Serum periostin levels showed no significant correlation with disease activity, as measured using Urticaria Activity Score-7 and Urticaria Control Test scores. IN PRACTICE: 'Serum periostin may provide insight into the immunological mechanisms underlying CSU in children,' the authors of the study wrote. 'Its potential utility should be further explored in longitudinal and interventional studies.' SOURCE: Gokce Velioglu Haslak, MD, with the Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey, was the corresponding author of the study, which was published online on June 24 in International Archives of Allergy and Immunology. LIMITATIONS: The cross-sectional design, small sample size, and a lack of standard pediatric periostin reference ranges complicated interpretation of the results. DISCLOSURES: The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
